Post-Menopausal Osteoporosis Clinical Trials

A listing of Post-Menopausal Osteoporosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

Denosumab of Intas is biosimilar denosumab candidate under development by Intas Pharmaceutical Limited (Biopharma Division). Denosumab of Intas is already approved by Indian drug licensing authority- Drug Controller General (India) for marketing in Indian population since 2018.As per regulatory requirement, a comparative clinical study to establish Pharmacokinetic, Pharmacodynamic and Immunogenicity …

hysterectomy
prolia
spotting
denosumab
x-rays
  • 0 views
  • 04 Oct, 2022
  • 1 location
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of MB09 [Proposed Denosumab Biosimilar] to Prolia® [EU-sourced] in Postmenopausal Osteoporosis (SIMBA Study)

This is a randomized, double-blind, parallel, multicenter, multinational study to compare the efficacy, pharmacokinetics, pharmacodynamics, safety and immunogenicity of MB09 versus Prolia® in postmenopausal women with osteoporosis

  • 0 views
  • 07 Oct, 2022
  • 47 locations
Study on Vascular Function, Sarcopenia and Pain in Treated Postmenopausal Osteoporosis (VASCO)

This study aims to follow a cohort of osteoporotic patients treated with anti-osteoporotic drugs and to evaluate the impact of these treatments on the osteoporosis-cardiovascular-sarcopenia triad and on pain.

  • 0 views
  • 24 Oct, 2022
  • 1 location
MAGnesium Effect With ANtiosteoporotic Drugs (MAGELLAN)

Randomized pilot clinical trial to demonstrate superiority of bisphosphonate-magnesium combination over bisphosphonates alone in postmenopausal osteoporosis in slowing bone remodeling as

type i collagen
bisphosphonate
sarcopenia
bisphosphonate therapy
  • 0 views
  • 08 Jul, 2022
  • 1 location
Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND (ALVOBOND)

This is a randomized, double-blind, parallel design, repeat dose, 2 arm, multicenter study comparing the efficacy, safety, immunogenicity, and PK profiles of AVT03 and Prolia in postmenopausal women with osteoporosis. After the screening activities, eligible subjects will be randomized in a 1:1 ratio to receive either AVT03 60 mg or …

prolia
denosumab
  • 0 views
  • 07 Oct, 2022
  • 1 location
Novel Combination Therapy for Osteoporosis in Men (Osteo-Men)

Osteoporotic fractures are a key health problem in older men. Although there are drugs approved to treat osteoporosis in men [bisphosphonates, denosumab, and teriparatide (TPTD) or PTH(1-34)], there is a lack of knowledge on how to use them effectively. TPTD is a potent bone anabolic drug, meaning that it builds …

  • 39 views
  • 26 Feb, 2022
  • 1 location
Comparative Efficacy and Safety Study of RGB-14-P and Prolia in Women With Postmenopausal Osteoporosis

postmenopausal osteoporosis, in a comparative manner.

x-ray absorptiometry
dual-energy x-ray absorptiometry
prolia
x-rays
postmenopausal osteoporosis
  • 8 views
  • 12 Mar, 2022
  • 30 locations
A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

This is a phase 3 Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Enzene Denosumab (ENZ215) and Prolia® in Postmenopausal Women with Osteoporosis

prolia
x-ray absorptiometry
denosumab
postmenopausal osteoporosis
  • 0 views
  • 04 Oct, 2022
  • 1 location
Anabolic Therapy in Postmenopausal Osteoporosis

In this research study we want to learn more about the effect of two different FDA-approved medications in the treatment of osteoporosis.

denosumab
Accepts healthy volunteers
romosozumab
postmenopausal osteoporosis
  • 0 views
  • 04 Oct, 2022
  • 1 location
DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women

To determine whether the musculoskeletal adaptations to bone-loading exercise can be significantly augmented in older women (aged 60-85) with low bone mass (osteopenia; T-scores <-1.0 and >-2.5) or moderate osteoporosis (T-scores < -2.5 and >= -3.0) and by restoring serum DHEAS to young adult levels by oral DHEA replacement.

osteopenia
Accepts healthy volunteers
treatment for osteoporosis
osteoporosis
bone mineral density
  • 23 views
  • 23 Mar, 2022
  • 1 location